Shareholder update

 2nd Apr 2015

EKF Diagnostics Holdings plc, the AIM listed point-of-care, central laboratory and molecular diagnostics business, announces that the Board of Directors have initiated a strategic review.

An independent committee of the Non-Executive Directors will lead the strategic review, chaired by Dr Kevin Wilson and consisting of Adam Reynolds, David Toohey and Doris Ann Williams.

The independent committee are committed to completing their review as soon as practicable.